Complement-mediated regulation of tissue factor activity in endothelium

Journal of Experimental Medicine

Volumn 182, Issue 6, 1995, Pages 1807-1814

  Saadi, Soheyla ^a   Holzknecht, Robert A ^a   Patte, Christian P ^a   Stern, David M ^b   Platt, Jeffrey L ^a  

^a DUKE UNIVERSITY   (United States)

^b Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1ALPHA; THROMBOPLASTIN;

ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; COMPLEMENT SYSTEM; HEMOSTASIS; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; SWINE; THROMBOGENESIS; VASCULAR ENDOTHELIUM;

AMINO ACID SEQUENCE; ANIMAL; BASE SEQUENCE; CELLS, CULTURED; COMPLEMENT; CYCLOHEXIMIDE; DNA PRIMERS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; INTERLEUKIN-1; MOLECULAR SEQUENCE DATA; PROTEIN SYNTHESIS INHIBITORS; RNA, MESSENGER; SUPPORT, U.S. GOV'T, P.H.S.; SWINE; THROMBOPLASTIN;

EID: 0028881851     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.182.6.1807     Document Type: Article

References (52)

1. Marcum, J.A., D.H. Atha, L.M. Fritze, P. Nawroth, D. Stem, and R.D. Rosenberg. 1986. Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparan sulfate proteoglycan. J. Biol. Chem. 261: 7507-7517.
2. Esmon, N.L., W.G. Owen, and C.T. Esmon. 1982. Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. J. Biol. Chem. 257: 859-864.
3. Rapaport, S.I. 1991. The extrinsic pathway inhibitor: a regulator of tissue factor-dependent blood coagulation. Thromb. Haemostasis. 66: 6-15.
4. Wilcox, J., K. Smith, S. Schwartz, and D. Gordon. 1989. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc. Natl. Acad. Sci. USA. 86: 2839-2843.
5. Nachman, R.L., K.A. Hajjar, R.L. Silverstein, and C.A. Dinarello. 1986. Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor. J. Exp. Med. 163: 1595-1600.
6. Bevilacqua, M.P., J.S. Pober, G.R. Majeau, R.S. Cotran, and M.A. Gimbrone, Jr. 1984. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J. Exp. Med. 160: 618-623.
7. Stem, D.M., I. Bank, P.P. Nawroth, J. Cassimeris, W. Kisiel, J. W. Fenton, II, C. Dinarello, L. Chess, and E.A. Jaffe. 1985. Self-regulation of procoagulant events on the endothelial cell surface. J. Exp. Med. 162: 1223-1235.
8. Nawroth, P.P., D.A. Handley, C.T. Esmon, and D.M. Stem. 1986. Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. Proc. Natl. Acad. Sci. USA. 83: 3460-3464.
9. Bevilacqua, M.P., R.R. Schleef, M.A. Gimbrone, Jr., and D.J. LoskutofF. 1986. Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin 1. J. Clin. Invest. 78: 587-591.
10. Colucci, M., G. Balconi, R. Lorenzet, A. Pietra, D. Locati, M. B. Donati, and N. Semerano. 1983. Cultured human endothelial cells generate tissue factor in response to endotoxin. J. Clin. Invest. 71: 1893-1896.
11. Nawroth, P.P., D.M. Stem, W. Kisiel, and R. Bach. 1985. Cellular requirements for tissue factor generation by bovine aortic endothelial cells in culture. Throm. Res. 40: 677-691.
12. Moore, K.L., S.P. Andreoli, N.L. Esmon, C.T. Esmon, and N. U. Bang. 1987. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J. Clin. Invest. 79: 124-130.
13. Roberts, H.R., and J.N. Lozier. 1992. New perspectives on the coagulation cascade. Hosp. Pract. 27: 97-112.
14. Arthus, M. 1903. Injections repetees de serum de cheval chez le lapin. C. R. Soc. Biol. (Paris). 55: 817-820.
15. Cochrane, C.G., W.O. Weigle, and F.J. Dixon. 1959. The role of polymorphonuclear leukocytes in the initiation and cessation of the arthus vaculitis. J. Exp. Med. 110: 481-501.
16. Cines, D.B., A.P. Lyss, M. Reeber, M. Bina, and R.J. DeHoratius. 1984. Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus. J. Clin. Invest. 73: 611-625.
17. Cines, D.B. 1989. Disorders associated with antibodies to endothelial cells. Rev. Infect. Dis. 11:S705-S711.
18. Germuth, F.G. 1953. A comparative histologic and immunologic study in rabbits of induced hypersensitivity of the serum sickness type. J. Exp. Med. 97: 257-282.
19. Lau, C.S., M. McLaren, J. Hanslip, M. Kerr, andJ.F. Belch. 1993. Abnormal plasma fibrinolysis in patients with rheumatoid arthritis and impaired endothelial fibrinolytic response in those complicated by vasculitis. Ann. Rheum. Dis. 52:643-649.
20. Leventhal, J.R., A.J. Matas, L.H. Sun, S. Reif, R.M. Bolman, III, A.P. Dalmasso, andJ.L. Platt. 1993. The immunopathology of cardiac xenograft rejection in the guinea pig to rat model. Transplantation (Baltimore). 56: 1-8.
21. Campbell, W.N., X. Ding, and S.E. Goldblum. 1992. Interleukin-1 a and -(3 augment pulmonary artery transendothelial albumin flux in vitro. Am. J. Physiol. 263:L128-L136.
22. Brett, J., H. Gerlach, P. Nawroth, S. Steinberg, G. Godman, and D. Stem. 1989. Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins. J. Exp. Med. 169: 1977-1991.
23. Saadi, S., andJ.L. Platt. 1995. Transient perturbation of endothelial integrity induced by antibodies and complement. J. Exp. Med. 181: 21-31.
24. Jaffe, E.A., R.L. Nachman, C.G. Becker, and C.R. Minick. 1973. Culture of human endothelial cells derived from umbilical veins. J. Clin. Invest. 52: 2745-2756.
25. Levin, J., and F.B. Bang. 1968. Clottable protein in Limulus: Its localization and kinetics of its coagulation by endotoxin. Thromb. Diath. Haemorrh. 19: 186-197.
26. Platt, J.L., M.A. Turman, H.J. Noreen, R.J. Fischel, R.M. Bolman, and F.FL Bach. 1990. An ELISA assay for xenoreactive natural antibodies. Transplantation (Baltimore). 49: 1000-1001.
27. Parker, W.R., D. Bruno, Z.E. Holzknecht, and J.L. Platt. 1994. Xenoreactive natural antibodies: isolation and initial characterization. J. Immunol. 153: 3791-3803.
28. Platt, J.L., B.J. Lindman, R.L. Geller, H.J. Noreen, J.L. Swanson, A.P. Dalmasso, and F.H. Bach. 1991. The role of natural antibodies in the activation of xenogenic endothelial cells. Transplantation (Baltimore). 52: 1037-1043.
29. Platt, J.L., and Z.E. Holzknecht. 1994. Porcine platelet antigens recognized by human xenoreactive natural antibodies. Transplantation (Baltimore). 57: 327-335.
30. Ryan, J., J. Brett, P. Tijburg, R.R. Bach, W. Kisiel, and D. Stern. 1992. Tumor necrosis factor-induced endothelial tissue factor is associated with subendothelial matrix vesicles but is not expressed on the apical surface. Blood. 80: 966-974.
31. Tijburg, P.N.M., J. Ryan, D.M. Stern, B. Wollitzky, S. Rimon, A. Rimon, D. Handley, P. Nawroth, J.J. Sixma, and P.G. de Groot. 1991. Activation of the coagulation mechanism on tumor necrosis factor-stimulated cultured endothelial cells and their extracellular matrix. J. Biol. Chem. 266: 12067-12074.
32. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal. Biochem. 162: 156-159.
33. Ponte, P., S. Ng, J. Engel, P. Gunning, and L. Kedes. 1984. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acids Res. 12: 1687-1696.
34. Spicer, E.K., R. Horton, L. Bloem, R. Bach, K.R. Williams, A. Guha, J. Kraus, T.-C. Lin, Y. Nemerson, and W.H. Konigsberg. 1987. Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA. Proc. Natl. Acad. Set. USA. 84: 5148-5152.
35. Ranganathan, G., S.P. Blatti, M. Subramaniam, D.N. Fass, N.J. Maihle, and M.J. Getz. 1991. Cloning of murine tissue factor and regulation of gene expression by transforming growth factor type bl.J. Biol. Chem. 266: 496-501.
36. Mackman, N., B.J. Fowler, T.S. Edgington, andJ.H. Morrissey. 1990. Functional analysis of the human tissue factor promoter and induction by serum. Proc. Natl. Acad. Sci. USA. 87: 2254-2258.
37. Collins, B.H., W.R. Parker, andJ.L. Platt. 1994. Characterization of porcine endothelial cell determinants recognized by human natural antibodies. Xenotransplantation. 1: 36-46.
38. Iida, K., and V. Nussenzweig. 1981. Complement receptor is an inhibitor of the complement cascade. J. Exp. Med. 153: 1138-1150.
39. Fei, H., J.A. Berliner, F. Parhami, and T.A. Drake. 1993. Regulation of endothelial cell tissue factor expression by minimally oxidized LDL and lipopolysaccharide. Arterioscler. Thromb. 13: 1711-1717.
40. Brand, K., B.J. Fowler, T.S. Edgington, and N. Mackman. 1991. Tissue factor mRNA in THP-1 monocytic cells is regulated at both transcriptional and posttranscriptional levels in response to lipopolysaccharide. Mol. Cell. Biol. 11: 4732-4738.
41. Yeh, C.G., H.C. Marsh, G.R. Carson, L. Berman, M.F. Concino, S.M. Scesney, R.E. Kuestner, R. Skibbens, K.A. Donahue, and S.H. Ip. 1991. Recombinant soluble human complement receptor type 1 inhibits inflammation in the reversed passive arthus reaction in rats. J. Immunol. 146: 250-256.
42. Nicholson-Weller, A., and J.A. Halperin. 1993. Membrane signaling by complement C5b-9, the membrane attack complex. Immunol. Res. 12: 244-257.
43. Niculescu, F., H. Rus, S. Shin, T. Lang, and M.L. Shin. 1993. Generation of diacylglycerol and ceramide during homologous complement activation. J. Immunol. 150: 214-224.
44. Carney, D.F., T.J. Lang, and M.L. Shin. 1990. Multiple signal messengers generated by terminal complement complexes and their role in terminal complement complex elimination. J. Immunol. 145: 623-629.
45. Car, B.D., D.O. Slauson, M. Dore, and M.M. Suyemoto. 1990. Endotoxin-mediated bovine alveolar macrophage procoagulant induction is dependent on protein kinase C activation. Inflammation. 14: 681-689.
46. Wakita, K., Y. Marumoto, and T. Horiuchi. 1994. Up-regulation of tissue factor mRNA in human umbilical vein endothelial cells by calmodulin inhibitor W7. Thromb. Res. 73: 177-184.
47. Wakita, K., D. Stearns-Kurosawa, and Y. Marumoto. 1994. The effect of calcium ionophore A23187 on tissue factor activity and mRNA in endothelial cells. Thromb. Res. 74:95-103.
48. Kolesnick, R., and D.W. Golde. 1994. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell. 77: 325-328.
49. Lee, W.Y., A.P. Butler, M.F. Locniskar, and S.M. Fischer. 1994. Signal transduction pathway(s) involved in phorbol ester and autocrine induction of interleukin-1 mRNA in murine keratinocytes. J. Biol. Chem. 269: 17971-17980.
50. Seeger, W., R. Hartmann, H. Neuhoff, and S. Bhakdi. 1989. Local complement activation, thromboxane-mediated vasoconstriction, and vascular leakage in isolated lungs. Am. Rev. Respir. Dis. 139: 88-99.
51. Platt, J.L., G.M. Vercellotti, B.J. Lindman, T.R. Oegema, Jr., F.H. Bach, and A.P. Dalmasso. 1990. Release of heparan sulfate from endothelial cells: implications for pathogenesis of hyperacute rejection. J. Exp. Med. 171: 1363-1368.
52. Dinarello, C.A. 1994. lnterleukin-1. Adv. Pharmacol. 25: 21-51.